Pnc Financial Services Group, Inc. Intra Cellular Therapies, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 8,034 shares of ITCI stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,034
Previous 8,391
4.25%
Holding current value
$1.06 Million
Previous $613,000
9.3%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ITCI
# of Institutions
418Shares Held
87.7MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$833 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$675 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$423 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...